GUSTAV CAPPAERT: Open Payments
NPI 1275017576 · ASHEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$649 in 37 payments from 16 companies in 2025. Trend: 2023 $175 · 2024 $320 · 2025 $649
Food & beverage: $649
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $176 |
| Indivior Inc. | 3 | $78 |
| AstraZeneca Pharmaceuticals LP | 4 | $70 |
| Novo Nordisk Inc | 3 | $50 |
| Lilly USA, LLC | 2 | $42 |
| Gilead Sciences, Inc. | 1 | $29 |
| PFIZER INC. | 2 | $28 |
| Seqirus USA Inc | 1 | $24 |
| Lundbeck LLC | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
Products named: VRAYLAR, SUBLOCADE, MOUNJARO, QULIPTA, NEXIUM, Flucelvax, REXULTI, UZEDY.
Industry payments across NC — which companies pay providers there.
